Original paper
Abstract B116: Nano-neo-mRNA vaccine: A novel platform technology for cancer-immunotherapy
Volume: 7, Issue: 2_Supplement, Pages: B116 - B116
Published: Feb 1, 2019
Abstract
Nanoparticle-based immunotherapeutic platforms are emerging as radically different, biocompatible alternatives for viral-vectors. Liposomal nanoplexes already showed potential for clinical translation of mutanome specific personalized cancer-vaccines in human. Here, we report a novel nanoparticle platform technology for neoantigen specific mRNA (neo-mRNA) vaccine delivery and demonstrated its potential for evoking T-cell mediated immune response...
Paper Details
Title
Abstract B116: Nano-neo-mRNA vaccine: A novel platform technology for cancer-immunotherapy
Published Date
Feb 1, 2019
Journal
Volume
7
Issue
2_Supplement
Pages
B116 - B116
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History